All FDA drug approvals
FDA data · free, no account
FDA drug approvals — brands starting with Y
24 FDA applications with an approved original submission carry a brand starting with Y, the earliest approved in 1976 and the most recent in 2026. FDA marks 3 of them discontinued, every product under the application. From the Drugs@FDA export of 2026-09-03.
| Brand | Ingredient | Approved | Sponsor | Application |
|---|---|---|---|---|
| YARTEMLEA | narsoplimab-wuug | OMEROS CORP | BLA761152 | |
| YASMIN | drospirenone, ethinyl estradiol | BAYER HLTHCARE | NDA021098 | |
| YAZ | drospirenone, ethinyl estradiol | BAYER HLTHCARE | NDA021676 | |
| YAZ | drospirenone, ethinyl estradiol | BAYER HLTHCARE | NDA021873 | |
| YAZ | drospirenone, ethinyl estradiol | BAYER HLTHCARE | NDA022045 | |
| YCANTH | cantharidin | VERRICA PHARMS | NDA212905 | |
| YERVOY | ipilimumab | BRISTOL MYERS SQUIBB | BLA125377 | |
| YESAFILI | aflibercept-jbvf | BIOCON BIOLOGICS INC | BLA761274 | |
| YESINTEK | ustekinumab-kfce | BIOCON BIOLOGICS INC | BLA761406 | |
| YEZTUGO | lenacapavir, lenacapavir sodium | GILEAD SCIENCES INC | NDA220018 | |
| YEZTUGO | lenacapavir sodium | GILEAD SCIENCES INC | NDA220020 | |
| YONDELIS | trabectedin | JANSSEN PRODS | NDA207953 | |
| YONSA | abiraterone acetate | SUN PHARM | NDA210308 | |
| YORVIPATH | palopegteriparatide | ASCENDIS PHARMA BONE | NDA216490 | |
| YOSPRALA | aspirin, omeprazole | GENUS LIFESCIENCES | NDA205103 | |
| YTTERBIUM YB 169 DTPA | pentetate calcium trisodium yb-169 | 3M | NDA017518 | |
| YUFLYMA | adalimumab-aaty | CELLTRION | BLA761219 | |
| YUPELRI | revefenacin | MYLAN IRELAND LTD | NDA210598 | |
| YUSIMRY | adalimumab-aqvh | EMERGE BIOSCIENCE PTE. LTD. | BLA761216 | |
| YUTIQ | fluocinolone acetonide | ALIMERA SCIENCES INC | NDA210331 | |
| YUTOPAR | ritodrine hydrochloride | ASTRAZENECA | NDA018555 | |
| YUTREPIA | treprostinil sodium | LIQUIDIA TECH | NDA213005 | |
| YUVEZZI | brimonidine tartrate, carbachol | VISUS | NDA220142 | |
| YUVIWEL | navepegritide | ASCENDIS | NDA219164 |